81 FR 8083 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 31 (February 17, 2016)

Page Range		8083-8083
FR Document		2016-03122

Federal Register, Volume 81 Issue 31 (Wednesday, February 17, 2016)

[Federal Register Volume 81, Number 31 (Wednesday, February 17, 2016)]
[Notices]
[Page 8083]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-03122]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Collaborative Projects in Organ Fibrosis.
    Date: March 8, 2016.
    Time: 8:30 a.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Kristen Page, Ph.D., Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, 6701 Rockledge Drive, Room 7185, Bethesda, MD 20892, 301-
435-0725, [email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Small Business Point of Care.
    Date: March 9, 2016.
    Time: 9:00 a.m. to 11:00 a.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Kristin Goltry, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7198, Bethesda, MD 
20892, 301-435-0297, [email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Small Business Point of Care.
    Date: March 9-10, 2016.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Kristin Goltry, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7198, Bethesda, MD 
20892, 301-435-0297, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: February 10, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-03122 Filed 2-16-16; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 31 / Wednesday, February 17, 2016 / Notices 8083

Manager, Technology Advancement The meetings will be closed to the DEPARTMENT OF HEALTH AND
Office, The National Institutes of public in accordance with the HUMAN SERVICES
Diabetes and Digestive and Kidney provisions set forth in sections
Diseases, 12A South Drive, Bethesda, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., National Institutes of Health
MD 20892, Telephone: (301) 451–5560; as amended. The grant applications and
Email: patrick.mccue@nih.gov. A signed the discussions could disclose Center for Scientific Review; Notice of
confidentiality non-disclosure confidential trade secrets or commercial Closed Meetings
agreement will be required to receive property such as patentable material, Pursuant to section 10(d) of the
copies of any patent applications that and personal information concerning Federal Advisory Committee Act, as
have not been published by the United individuals associated with the grant amended (5 U.S.C. App.), notice is
States Patent and Trademark Office or applications, the disclosure of which hereby given of the following meetings.
the World Intellectual Property would constitute a clearly unwarranted The meetings will be closed to the
Organization. invasion of personal privacy. public in accordance with the
SUPPLEMENTARY INFORMATION: These Name of Committee: National Heart, Lung, provisions set forth in sections
technologies, and the corresponding and Blood Institute Special Emphasis Panel; 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
patent applications, are directed to Collaborative Projects in Organ Fibrosis. as amended. The grant applications and
cyclopentane-peptide nucleic acids Date: March 8, 2016. the discussions could disclose
(PNA) and their use in qualitative and Time: 8:30 a.m. to 4:30 p.m. confidential trade secrets or commercial
quantitative detection of nucleic acids. Agenda: To review and evaluate grant property such as patentable material,
The technologies overcome a stability applications. and personal information concerning
Place: Courtyard by Marriott, 5520 individuals associated with the grant
problem and sensitivity to outside
Wisconsin Avenue, Chevy Chase, MD 20815.
contamination that is inherent to PCR- applications, the disclosure of which
Contact Person: Kristen Page, Ph.D.,
based detection systems, wherein the Scientific Review Officer, Office of Scientific would constitute a clearly unwarranted
PNA probes bind to DNA with greater Review/DERA, National Heart, Lung, and invasion of personal privacy.
stability and selectivity compared to a Blood Institute, 6701 Rockledge Drive, Room Name of Committee: Center for Scientific
complementary DNA sequence. 7185, Bethesda, MD 20892, 301–435–0725, Review Special Emphasis Panel, PAR–14–
The prospective exclusive license will kristen.page@nih.gov. 166: Early Phase Clinical Trials in Imaging
be royalty bearing and will comply with Name of Committee: National Heart, Lung, and Image-Guided Interventions (R01).
the terms and conditions of 35 U.S.C. and Blood Institute Special Emphasis Panel; Date: February 29, 2016.
209 and 37 CFR part 404. The Small Business Point of Care. Time: 1:00 p.m. to 4:00 p.m.
prospective exclusive license may be Date: March 9, 2016. Agenda: To review and evaluate grant
Time: 9:00 a.m. to 11:00 a.m. applications.
granted unless within fifteen (15) days
Agenda: To review and evaluate grant Place: National Institutes of Health, 6701
from the date of this published notice, Rockledge Drive, Bethesda, MD 20892,
the Technology Advancement Office, applications.
(Telephone Conference Call).
NIDDK, receives written evidence and Place: Bethesda Marriott Suites, 6711
Contact Person: David L Williams, Ph.D.,
Democracy Boulevard, Bethesda, MD 20817.
argument that establishes that the grant Scientific Review Officer, Center for
Contact Person: Kristin Goltry, Ph.D.,
of the license would not be consistent Scientific Review, National Institutes of
Scientific Review Officer, Office of Scientific Health, 6701 Rockledge Drive, Room 5110,
with the requirements of 35 U.S.C. 209 Review/DERA, National Heart, Lung, and
and 37 CFR part 404. MSC 7854, Bethesda, MD 20892, (301) 435–
Blood Institute, 6701 Rockledge Drive, Room 1174, williamsdl2@csr.nih.gov.
Properly filed competing applications 7198, Bethesda, MD 20892, 301–435–0297,
for a license in response to this notice Name of Committee: Center for Scientific
goltrykl@mail.nih.gov.
will be treated as objections to the Review Special Emphasis Panel, Topics in
Name of Committee: National Heart, Lung, Bacterial Pathogenesis.
contemplated license. Comments and and Blood Institute Special Emphasis Panel; Date: March 9, 2016.
objections submitted in response to this Small Business Point of Care. Time: 8:00 a.m. to 6:00 p.m.
notice will not be made available for Date: March 9–10, 2016. Agenda: To review and evaluate grant
public inspection and, to the extent Time: 11:00 a.m. to 5:00 p.m. applications.
permitted by law, will not be released Agenda: To review and evaluate grant Place: Residence Inn Bethesda, 7335
under the Freedom of Information Act, applications. Wisconsin Avenue, Bethesda, MD 20814.
5 U.S.C. 552. Place: Bethesda Marriott Suites, 6711 Contact Person: Richard G Kostriken,
Democracy Boulevard, Bethesda, MD 20817. Ph.D., Scientific Review Officer, Center for
Dated: February 10, 2016. Contact Person: Kristin Goltry, Ph.D., Scientific Review, National Institutes of
Anna Amar, Scientific Review Officer, Office of Scientific Health, 6701 Rockledge Drive, Room 3192,
Acting Deputy Director, Technology Review/DERA, National Heart, Lung, and MSC 7808, Bethesda, MD 20892, 240–519–
Advancement Office, NIDDK. Blood Institute, 6701 Rockledge Drive, Room 7808, kostrikr@csr.nih.gov.
[FR Doc. 2016–03187 Filed 2–16–16; 8:45 am]
7198, Bethesda, MD 20892, 301–435–0297, Name of Committee: Center for Scientific
goltrykl@mail.nih.gov. Review Special Emphasis Panel; Small
BILLING CODE 4140–01–P
Business: Digestive Sciences.
(Catalogue of Federal Domestic Assistance
Date: March 9, 2016.
Program Nos. 93.233, National Center for
Time: 8:00 a.m. to 7:00 p.m.
DEPARTMENT OF HEALTH AND Sleep Disorders Research; 93.837, Heart and
Agenda: To review and evaluate grant
HUMAN SERVICES Vascular Diseases Research; 93.838, Lung applications.
Diseases Research; 93.839, Blood Diseases Place: Cambria Hotel & Suites, 1 Helen
asabaliauskas on DSK5VPTVN1PROD with NOTICES

National Institutes of Health and Resources Research, National Institutes Heneghan Way, Rockville, MD 20850.
of Health, HHS) Contact Person: Martha Garcia, Ph.D.,
National Heart, Lung, and Blood Dated: February 10, 2016. Scientific Reviewer Officer, Center for
Institute; Notice of Closed Meetings Michelle Trout, Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2186,
Pursuant to section 10(d) of the Program Analyst, Office of Federal Advisory MSC 7818, Bethesda, MD 20892, 301–435–
Federal Advisory Committee Act, as Committee Policy. 1243, garciamc@nih.gov.
amended (5 U.S.C. App.), notice is [FR Doc. 2016–03122 Filed 2–16–16; 8:45 am] Name of Committee: Center for Scientific
hereby given of the following meetings. BILLING CODE 4140–01–P Review Special Emphasis Panel;

VerDate Sep<11>2014 19:05 Feb 16, 2016 Jkt 238001 PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\17FEN1.SGM 17FEN1

Document Created: 2016-02-17 01:16:36
Document Modified: 2016-02-17 01:16:36

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		March 8, 2016.
FR Citation		81 FR 8083

81 FR 8083 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 31 (February 17, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health